TCT 2019 | STS/ACC TVT Registry: Relationship Between MitraClip Operator Experience and Events

Courtesy of SBHCI.

Mitral valve repair with a MitraClip device is a complex procedure that requires that operators develop a series of skills that may be unusual for them, such as analyzing an echocardiography.

Highlights TCT 2019

In this registry, researchers assessed the relationship between operator experience and procedural outcome.

Operators were classified into 3 groups: 1 to 25 procedures conducted, 26 to 50 procedures conducted, and 50+ procedures conducted. Researchers assessed the rates of procedural success, procedural time, and in-hospital complications.

The study analyzed 14,923 MitraClip procedures conducted by 562 operators in 290 sites. Optimal success rates (regarded as mitral regurgitation grade 1 or less) increased alongside operator experience (63.9%, 68.4%, and 75.1%, respectively; p < 0.0001). Acceptable success rates (regarded as regurgitation grade 2 or less) also increased alongside the number of procedures conducted (91.4%, 92.4%, and 93.8%; p < 0.001).

The cutoff point as regards the success rate and the rate of complications was clear at 50 procedures, but outcomes continued improving up to 200 procedures.

Courtesy of SBHCI.

Link to the SBHCI publication HERE

Registro-STS-ACC-TVT

Original Title: STS/ACC TVT Registry: MitraClip Operator Volume-Outcome Relationship in the United States.

Author of the original title: Adnan K. Chhatriwalla.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...